Thomas M Siler

3PUBLICATIONS
6CO-AUTHORS
PharmacogenomicsClinical pharmacology and therapeuticsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 19, 2026
Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease.

Thomas M Siler, Tara Rheault, Daniel Reyner

|Jun 26, 2023
Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials).

Antonio Anzueto, Igor Z Barjaktarevic, Thomas M Siler

|Aug 15, 2022
Correct use and ease-of-use of placebo ELLIPTA dry-powder inhaler in adult patients with chronic obstructive pulmonary disease.

Thomas M Siler, Renu Jain, Kathryn Collison

Pageof 1

Frequent Collaborators

1 joint publications

Renu Jain

1 joint publications

Igor Z Barjaktarevic

1 joint publications

Frank Sciurba

1 joint publications

Daniel Reyner